Literature DB >> 5901746

Mithramycin inhibition of ribonucleic acid synthesis.

J W Yarbro, B J Kennedy, C P Barnum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5901746

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  19 in total

Review 1.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.

Authors:  Tristan M Sissung; Phoebe A Huang; Ralph J Hauke; Edel M McCrea; Cody J Peer; Roberto H Barbier; Jonathan D Strope; Ariel M Ley; Mary Zhang; Julie A Hong; David Venzon; Jonathan P Jackson; Kenneth R Brouwer; Patrick Grohar; Jon Glod; Brigitte C Widemann; Theo Heller; David S Schrump; William D Figg
Journal:  Mol Pharmacol       Date:  2019-06-07       Impact factor: 4.436

Review 4.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 5.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease.

Authors:  V Parsons; M Baum; M Self
Journal:  Br Med J       Date:  1967-02-25

7.  Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia.

Authors:  E Archimbaud; J Troncy; C Sebban; D Guyotat; Y Devaux; M French; M Moriceau; J J Viala; D Fiere
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  In vivo differentiation of blast-phase chronic granulocytic leukemia. Expression of c-myc and c-abl protooncogenes.

Authors:  C A Koller; V W Campbell; D A Polansky; A Mulhern; D M Miller
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Effect of mithramycin on bone beta-glucuronidase and resorption.

Authors:  D T Kiang
Journal:  Calcif Tissue Res       Date:  1978-12-08

10.  Mithramycin therapy in Paget's disease.

Authors:  A S Russell; B C Lentle
Journal:  Can Med Assoc J       Date:  1974-02-16       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.